Tag: Oncology

Knight Therapeutics to Commercialise US Cancer Drug in Canada

Canada-based Knight Therapeutics signed an exclusive licence agreement with Puma Biotechnology to commercialise Nerlynx (neratinib) medicine in the country. Nerlynx is intended for the extended adj...

Agenus to Leverage Selexis’ Modular SUREtechnology Platform

Selexis has expanded its alliance with clinical-stage immuno-oncology company Agenus by signing additional commercial license agreements (CLAs). Under the new CLAs, Agenus will leverage Selexis’ mo...

Liver Cancer Drug of Bayer has Final NICE Recommendation

bayer
Bayer’s Stivarga has received a final green light from the National Institute for Health and Care Excellence (NICE) for use by the NHS to treat advanced liver cancer. Stivarga (regorafenib) is reco...

China and US to Research Novel Tumor Cells Antigen

Adagene, Inc., an innovative antibody discovery and engineering company, today announced a collaboration with Dr. Richard Childs, Chief of the Laboratory of Transplantation Immunotherapy at the Nation...

AbbVie and Tizona to Develop Antibody for Cancer Treatment

AbbVie, a research-based global biopharmaceutical company, and Tizona Therapeutics, Inc., a privately held immunotherapy company, announced on Jan. 3, 2019 that they have entered into a global, strate...

UK Researches to Develop Cancer Breath Test

Cancer Research UK and Owlstone Medical have launched a clinical trial to develop a breath test that could detect cancer at an early stage – the first test of its kind to investigate multiple cancer t...

Almac Brings Online Second GMP Peptide Facility

Based in Edinburgh, Scotland, the facility manufactures neoantigen derived peptides for use in the production of patient specific, individualised cancer vaccines Almac Group has brought online a se...

First Patient Dosed in First-Line Treatment of Advanced Cancer

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines, announced that the first patient has been dosed in a phase III clinical trial...

Another Positive CHMP Opinion from EMA for Pfizer

pfizer
Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended marketing authorization for Zirabe...

Fast Track for Neurological and Psychiatric Diseases Drug

The FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting from neurological and psychiatric disorders like Alzheimer’s and schizophreni...

Xynomic Files 3 IND Applications to Test Abexinostat

Xynomic Pharma, a clinical stage US-China oncology drug development company, today announced that its Trials-in-Progress poster discussing the ongoing, potentially pivotal, phase 3 trial of abexinosta...

FDA Pushes Back Decision Date for Keytruda Review

US regulators have pushed back the deadline for their review of Merck & Co’s immunotherapy Keytruda in certain patients with untreated lung cancer, after the pharmaceutical company submitted new d...

Biocept Entered into Laboratory Data Supply Agreement with Prognos

Biocept, Inc., a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, has...

CBT Pharmaceuticals and Strata Oncology agreed on Partnership

CBT Pharmaceuticals (CBT), Inc., a U.S. and China-based innovative pharmaceutical company, and Strata Oncology, Inc., a precision oncology company, today announced that the companies have entered into...